Publication | Closed Access

CEA and CA19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA)

Tumor BiologyMedicineCancer ManagementMetronomic TherapyFolinic AcidPathologyColorectal CancerMetastatic Colorectal CancerCancer TreatmentOncologyTumor MicroenvironmentNuclear MedicineCancer ResearchCa19-9 MeasurementRadiology